The Complete Blood Count (CBC) + Peripheral Smear Test is a combination of a blood count assessing red and white blood cells, platelets, hemoglobin, and hematocrit, along with a microscopic examination of blood cells to identify abnormalities and provide a comprehensive evaluation of blood health

CD4 count is a blood test that measures the number of CD4 cells, a type of white blood cell crucial for immune function. It’s primarily used to monitor the health of the immune system in people with HIV, as HIV destroys CD4 cells. This test helps assess the stage of HIV infection, guide treatment decisions, and predict the risk of opportunistic infections.

Leukemia/Lymphoma Screening Panel: A flow cytometry-based test using a panel of antibodies to identify and quantify various white blood cell populations in blood or bone marrow. It aids in the initial screening and diagnosis of potential blood cancers like leukemia and lymphoma.

This blood test detects the presence of the HLA-B27 protein, a genetic marker associated with certain autoimmune diseases, particularly those affecting the joints and spine, like ankylosing spondylitis. A positive result doesn’t confirm a diagnosis but indicates an increased risk of developing these conditions.

This blood test measures the number and proportion of specific types of immune cells (T-lymphocytes) – CD3+, CD4+, and CD8+ cells. It is used to assess immune function, monitor HIV infection, and diagnose certain immunodeficiency disorders.

This blood test measures the number and proportion of different types of lymphocytes (T cells, B cells, and Natural Killer cells) in your blood. It helps assess immune function, diagnose immunodeficiency disorders, and monitor conditions like HIV infection.

This flow cytometry test quantifies B cells (CD19+/CD20+ lymphocytes) in blood. It helps diagnose and monitor conditions like B-cell deficiencies, leukemias, lymphomas, and autoimmune diseases.

This genetic test uses next-generation sequencing (NGS) to analyze the BRCA1 and BRCA2 genes for inherited mutations associated with increased breast and ovarian cancer risk. It helps assess individual cancer risk and guide preventative measures.

This genetic test uses next-generation sequencing (NGS) to analyze tumor tissue for acquired mutations (somatic) in the BRCA1 and BRCA2 genes, which are associated with increased breast and ovarian cancer risk. It helps determine eligibility for targeted therapies like PARP inhibitors and guide treatment decisions.

This blood test measures specific IgE antibodies and component-resolved diagnostics (CRD) to identify allergies to a wide range of allergens, including food, pollen, mold, animal dander, and insect venom. It helps diagnose specific allergies, guide allergen avoidance, and personalize treatment plans.